Treatment of relapsed AML and MDS after allogeneic stem cell transplantation with decitabine and DLI: a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group

In contrast to the evidence regarding azacitidine (Aza), there is limited knowledge about the combination of decitabine (DAC) and donor lymphocyte infusions as salvage therapy for relapse after allogeneic stem cell transplantation (allo-SCT) so far. We retrospectively analyzed data of 36 patients wi...

Full description

Saved in:
Bibliographic Details
Main Authors: Schroeder, Thomas (Author) , Rautenberg, Christina (Author) , Krüger, William H. (Author) , Platzbecker, Uwe (Author) , Bug, Gesine (Author) , Steinmann, Juliane (Author) , Klein, Stefan (Author) , Hopfer, Olaf (Author) , Nachtkamp, Kathrin (Author) , Kondakci, Mustafa (Author) , Geyh, Stefanie (Author) , Haas, Rainer (Author) , Germing, Ulrich (Author) , Bornhäuser, Martin (Author) , Kobbe, Guido (Author)
Format: Article (Journal)
Language:English
Published: 2018
In: Annals of hematology
Year: 2017, Volume: 97, Issue: 2, Pages: 335-342
ISSN:1432-0584
DOI:10.1007/s00277-017-3185-5
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00277-017-3185-5
Get full text
Author Notes:Thomas Schroeder, Christina Rautenberg, William Krüger, Uwe Platzbecker, Gesine Bug, Juliane Steinmann, Stefan Klein, Olaf Hopfer, Kathrin Nachtkamp, Mustafa Kondakci, Stefanie Geyh, Rainer Haas, Ulrich Germing, Martin Bornhäuser, Guido Kobbe

MARC

LEADER 00000caa a2200000 c 4500
001 1696786886
003 DE-627
005 20240405193248.0
007 cr uuu---uuuuu
008 200428r20182017xx |||||o 00| ||eng c
024 7 |a 10.1007/s00277-017-3185-5  |2 doi 
035 |a (DE-627)1696786886 
035 |a (DE-599)KXP1696786886 
035 |a (OCoLC)1341317465 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Schroeder, Thomas  |d 1980-  |e VerfasserIn  |0 (DE-588)1138227749  |0 (DE-627)895546574  |0 (DE-576)492416435  |4 aut 
245 1 0 |a Treatment of relapsed AML and MDS after allogeneic stem cell transplantation with decitabine and DLI  |b a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group  |c Thomas Schroeder, Christina Rautenberg, William Krüger, Uwe Platzbecker, Gesine Bug, Juliane Steinmann, Stefan Klein, Olaf Hopfer, Kathrin Nachtkamp, Mustafa Kondakci, Stefanie Geyh, Rainer Haas, Ulrich Germing, Martin Bornhäuser, Guido Kobbe 
264 1 |c 2018 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a /Published online: 18 November 2017 
500 |a Gesehen am 27.04.2020 
520 |a In contrast to the evidence regarding azacitidine (Aza), there is limited knowledge about the combination of decitabine (DAC) and donor lymphocyte infusions as salvage therapy for relapse after allogeneic stem cell transplantation (allo-SCT) so far. We retrospectively analyzed data of 36 patients with hematological (n = 35) or molecular relapse (n = 1) of acute myeloid leukemia (AML, n = 29) or myelodysplastic syndrome (MDS, n = 7) collected from 6 German transplant centers. Patients were treated with a median of 2 cycles DAC (range, 1 to 11). DAC was the first salvage therapy in 16 patients (44%), whereas 20 patients (56%) had previously received 1 to 5 lines of salvage therapy including 16 of them had been treated with Aza. In 22 patients (61%), a median of 2 DLI per patient (range, 1 to 5) was administered in addition to DAC. As a result, overall response rate was 25% including 6 complete remissions (CR, 17%) and 3 partial remissions (PR, 8%). Three patients within the first-line group achieved CR, while also 3 patients receiving DAC as second-line treatment reached CR including 2 patients with previous Aza failure. Median duration of CR was 10 months (range, 2 to 33) and no patient relapsed so far. The 2-year OS rate was 11% (± 6%) without any difference between first-line and pretreated patients. Incidence of acute and chronic graft-versus-host disease was 19 and 5%. Taken together, DAC exerts clinical efficacy in patients with AML or MDS relapsing after allo-SCT and is able to induce durable remissions in individual patients suggesting that DAC may be an alternative to Aza or even a second choice after Aza failure. 
534 |c 2017 
700 1 |a Rautenberg, Christina  |e VerfasserIn  |0 (DE-588)1184308276  |0 (DE-627)1663465401  |4 aut 
700 1 |a Krüger, William H.  |e VerfasserIn  |0 (DE-588)1206346620  |0 (DE-627)1692338781  |4 aut 
700 1 |a Platzbecker, Uwe  |e VerfasserIn  |0 (DE-588)115567089  |0 (DE-627)647686228  |0 (DE-576)337938695  |4 aut 
700 1 |a Bug, Gesine  |e VerfasserIn  |0 (DE-588)1055034617  |0 (DE-627)792579704  |0 (DE-576)411120158  |4 aut 
700 1 |a Steinmann, Juliane  |d 1987-  |e VerfasserIn  |0 (DE-588)1116350491  |0 (DE-627)870294830  |0 (DE-576)478307233  |4 aut 
700 1 |a Klein, Stefan  |e VerfasserIn  |0 (DE-588)1042491836  |0 (DE-627)769066372  |0 (DE-576)393988791  |4 aut 
700 1 |a Hopfer, Olaf  |e VerfasserIn  |0 (DE-588)1165821613  |0 (DE-627)1029885702  |0 (DE-576)510553249  |4 aut 
700 1 |a Nachtkamp, Kathrin  |e VerfasserIn  |4 aut 
700 1 |a Kondakci, Mustafa  |d 1971-  |e VerfasserIn  |0 (DE-588)131741608  |0 (DE-627)513325182  |0 (DE-576)298710250  |4 aut 
700 1 |a Geyh, Stefanie  |e VerfasserIn  |0 (DE-588)1058751352  |0 (DE-627)797489606  |0 (DE-576)414884833  |4 aut 
700 1 |a Haas, Rainer  |d 1955-  |e VerfasserIn  |0 (DE-588)173773524  |0 (DE-627)698678141  |0 (DE-576)134613805  |4 aut 
700 1 |a Germing, Ulrich  |d 1965-  |e VerfasserIn  |0 (DE-588)114105774  |0 (DE-627)607396474  |0 (DE-576)309781612  |4 aut 
700 1 |a Bornhäuser, Martin  |d 1966-  |e VerfasserIn  |0 (DE-588)1167559118  |0 (DE-627)1031176071  |0 (DE-576)511198817  |4 aut 
700 1 |a Kobbe, Guido  |d 1967-  |e VerfasserIn  |0 (DE-588)122013174  |0 (DE-627)08168181X  |0 (DE-576)293047596  |4 aut 
773 0 8 |i Enthalten in  |t Annals of hematology  |d Berlin : Springer, 1991  |g 97(2018), 2, Seite 335-342  |h Online-Ressource  |w (DE-627)253389852  |w (DE-600)1458429-3  |w (DE-576)072283157  |x 1432-0584  |7 nnas  |a Treatment of relapsed AML and MDS after allogeneic stem cell transplantation with decitabine and DLI a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group 
773 1 8 |g volume:97  |g year:2018  |g number:2  |g pages:335-342  |g extent:8  |a Treatment of relapsed AML and MDS after allogeneic stem cell transplantation with decitabine and DLI a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group 
856 4 0 |u https://doi.org/10.1007/s00277-017-3185-5  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20200428 
993 |a Article 
994 |a 2018 
998 |g 1042491836  |a Klein, Stefan  |m 1042491836:Klein, Stefan  |d 60000  |d 61200  |e 60000PK1042491836  |e 61200PK1042491836  |k 0/60000/  |k 1/60000/61200/  |p 7 
999 |a KXP-PPN1696786886  |e 363987031X 
BIB |a Y 
SER |a journal 
JSO |a {"origin":[{"dateIssuedKey":"2018","dateIssuedDisp":"2018"}],"person":[{"given":"Thomas","display":"Schroeder, Thomas","role":"aut","family":"Schroeder"},{"role":"aut","family":"Rautenberg","given":"Christina","display":"Rautenberg, Christina"},{"role":"aut","family":"Krüger","given":"William H.","display":"Krüger, William H."},{"display":"Platzbecker, Uwe","given":"Uwe","family":"Platzbecker","role":"aut"},{"family":"Bug","role":"aut","display":"Bug, Gesine","given":"Gesine"},{"family":"Steinmann","role":"aut","display":"Steinmann, Juliane","given":"Juliane"},{"display":"Klein, Stefan","given":"Stefan","family":"Klein","role":"aut"},{"given":"Olaf","display":"Hopfer, Olaf","role":"aut","family":"Hopfer"},{"role":"aut","family":"Nachtkamp","given":"Kathrin","display":"Nachtkamp, Kathrin"},{"family":"Kondakci","role":"aut","display":"Kondakci, Mustafa","given":"Mustafa"},{"display":"Geyh, Stefanie","given":"Stefanie","family":"Geyh","role":"aut"},{"family":"Haas","role":"aut","display":"Haas, Rainer","given":"Rainer"},{"given":"Ulrich","display":"Germing, Ulrich","role":"aut","family":"Germing"},{"given":"Martin","display":"Bornhäuser, Martin","role":"aut","family":"Bornhäuser"},{"display":"Kobbe, Guido","given":"Guido","family":"Kobbe","role":"aut"}],"id":{"eki":["1696786886"],"doi":["10.1007/s00277-017-3185-5"]},"note":["/Published online: 18 November 2017","Gesehen am 27.04.2020"],"title":[{"subtitle":"a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group","title":"Treatment of relapsed AML and MDS after allogeneic stem cell transplantation with decitabine and DLI","title_sort":"Treatment of relapsed AML and MDS after allogeneic stem cell transplantation with decitabine and DLI"}],"recId":"1696786886","name":{"displayForm":["Thomas Schroeder, Christina Rautenberg, William Krüger, Uwe Platzbecker, Gesine Bug, Juliane Steinmann, Stefan Klein, Olaf Hopfer, Kathrin Nachtkamp, Mustafa Kondakci, Stefanie Geyh, Rainer Haas, Ulrich Germing, Martin Bornhäuser, Guido Kobbe"]},"physDesc":[{"extent":"8 S."}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"relHost":[{"recId":"253389852","physDesc":[{"extent":"Online-Ressource"}],"title":[{"subtitle":"organ of: Gesellschaft für Thrombose- und Hämostaseforschung, DGHO, Deutsche Gesellschaft für Hämatologie und Onkologie e.V., ÖGHO, Österreichische Gesellschaft für Hämatologie und Onkologie","title_sort":"Annals of hematology","title":"Annals of hematology"}],"disp":"Treatment of relapsed AML and MDS after allogeneic stem cell transplantation with decitabine and DLI a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study GroupAnnals of hematology","titleAlt":[{"title":"Hematology"}],"part":{"year":"2018","text":"97(2018), 2, Seite 335-342","extent":"8","issue":"2","volume":"97","pages":"335-342"},"note":["Gesehen am 24.04.2025","Fortsetzung der Druck-Ausgabe","Ungezählte Beil. ab 80.2001: Supplement"],"id":{"eki":["253389852"],"zdb":["1458429-3"],"issn":["1432-0584"]},"origin":[{"publisher":"Springer","dateIssuedDisp":"1991-","publisherPlace":"Berlin ; Heidelberg ; New York","dateIssuedKey":"1991"}],"pubHistory":["62, 1 (Februrary 1991)-"],"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"}}]} 
SRT |a SCHROEDERTTREATMENTO2018